Literature DB >> 16763464

Osteoclasts, rheumatoid arthritis, and osteoimmunology.

Kojiro Sato1, Hiroshi Takayanagi.   

Abstract

PURPOSE OF REVIEW: Osteoclasts are terminally differentiated cells of the monocyte/macrophage lineage that resorb bone matrix. Bone destruction in rheumatoid arthritis is mainly attributable to the abnormal activation of osteoclasts, and studies on activation of osteoclasts by the immune system have led to the new research field called osteoimmunology. This interdisciplinary field is very important to biologic research and to the treatment of diseases associated with the bone and immune systems. RECENT
FINDINGS: The T-cell-mediated regulation of osteoclast differentiation is dependent on cytokines and membrane-bound factors expressed by T cells. The cross-talk between receptor activator of nuclear factor-kappaB ligand and interferon-gamma has been shown to be crucial for the regulation of osteoclast formation in arthritic joints. Recent studies indicate that an increasing number of immunomodulatory factors are associated with the regulation of bone metabolism: nuclear factor of activated T cells c1 has been shown to be the key transcription factor for osteoclastogenesis, the activation of which requires calcium signaling induced by the immunoglobulin-like receptors.
SUMMARY: New findings in osteoimmunology will be instrumental in the development of strategies for research into the treatment of various diseases afflicting the skeletal and immune systems.

Entities:  

Mesh:

Year:  2006        PMID: 16763464     DOI: 10.1097/01.bor.0000231912.24740.a5

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  75 in total

1.  Microarray-based gene expression profiling reveals the mediators and pathways involved in the anti-arthritic activity of Celastrus-derived Celastrol.

Authors:  Hua Yu; Shivaprasad H Venkatesha; Kamal D Moudgil
Journal:  Int Immunopharmacol       Date:  2012-06-02       Impact factor: 4.932

Review 2.  Osteoclastogenesis and arthritis.

Authors:  Nicola Maruotti; Maria Grano; Silvia Colucci; Francesca d'Onofrio; Francesco Paolo Cantatore
Journal:  Clin Exp Med       Date:  2010-11-11       Impact factor: 3.984

3.  microRNA Expression in Rat Apical Periodontitis Bone Lesion.

Authors:  Bo Gao; Liwei Zheng
Journal:  Bone Res       Date:  2013-06-28       Impact factor: 13.567

4.  Changes of serum levels of MMP-3, sRANKL, and OPG in juvenile-onset ankylosing spondylitis patients carrying different HLA-B27 subtypes.

Authors:  Yi-Kun Mou; Ping-Ping Zhang; Qiu-Xia Li; Zhi-Ming Lin; Ze-Tao Liao; Qiu-Jing Wei; Jie-Ruo Gu
Journal:  Clin Rheumatol       Date:  2015-04-26       Impact factor: 2.980

5.  Effect of bisphosphonates treatment on cytokine imbalance between TH17 and Treg in osteoporosis.

Authors:  Roba M Talaat; Asmaa Sidek; Ahmed Mosalem; Ahmed Kholief
Journal:  Inflammopharmacology       Date:  2015-04-25       Impact factor: 4.473

6.  Identification of a Novel Role for Foxo3 Isoform2 in Osteoclastic Inhibition.

Authors:  Cheng Xu; Gregory J Vitone; Kazuki Inoue; Courtney Ng; Baohong Zhao
Journal:  J Immunol       Date:  2019-09-20       Impact factor: 5.422

7.  MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients.

Authors:  Takuya Niimoto; Tomoyuki Nakasa; Masakazu Ishikawa; Atsushi Okuhara; Bunichiro Izumi; Masataka Deie; Osami Suzuki; Nobuo Adachi; Mitsuo Ochi
Journal:  BMC Musculoskelet Disord       Date:  2010-09-15       Impact factor: 2.362

8.  A novel in vivo gene transfer technique and in vitro cell based assays for the study of bone loss in musculoskeletal disorders.

Authors:  Dennis J Wu; Neha Dixit; Erika Suzuki; Thanh Nguyen; Hyun Seock Shin; Jack Davis; Emanual Maverakis; Iannis E Adamopoulos
Journal:  J Vis Exp       Date:  2014-06-08       Impact factor: 1.355

9.  Water-soluble fullerene (C60) inhibits the osteoclast differentiation and bone destruction in arthritis.

Authors:  Kazuo Yudoh; Rie Karasawa; Kayo Masuko; Tomohiro Kato
Journal:  Int J Nanomedicine       Date:  2009-10-19

10.  Water-soluble fullerene (C60) inhibits the development of arthritis in the rat model of arthritis.

Authors:  Kazuo Yudoh; Rie Karasawa; Kayo Masuko; Tomohiro Kato
Journal:  Int J Nanomedicine       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.